![](/images/ico/ico_close.png)
![](/images/ico/ico3.png)
Period of time: 2014年2期
Publisher: Informa Healthcare
Founded in: 2002
Total resources: 54
ISSN: 1474-0338
Subject: R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Drug Safety,volume 9,issue 2
Menu
![](/images/ico/ico5.png)
By Kontoghiorghes G J,Kolnagou A,Peng C-T,Shah S V,Aessopos A in (2010)
Expert Opinion on Drug Safety,volume 9,issue 2 , Vol. 9, Iss. 2, 2010-03 , pp.![](/images/ico/ico5.png)
By Li Jia,Merl Manyee,Lee Mike X,Kaley Kristin,Saif Muhammad W in (2010)
Expert Opinion on Drug Safety,volume 9,issue 2 , Vol. 9, Iss. 2, 2010-03 , pp.![](/images/ico/ico5.png)
Drug interactions with antiretrovirals and warfarin
By Liedtke Michelle D,Rathbun R Chris in (2010)
Expert Opinion on Drug Safety,volume 9,issue 2 , Vol. 9, Iss. 2, 2010-03 , pp.![](/images/ico/ico5.png)
By Holstein Andreas,Stege Helger,Kovacs Peter in (2010)
Expert Opinion on Drug Safety,volume 9,issue 2 , Vol. 9, Iss. 2, 2010-03 , pp.![](/images/ico/ico5.png)
Safety and efficacy of over- the-counter cough and cold medicines for use in children
By Vassilev Zdravko P,Kabadi Shaum,Villa Raul in (2010)
Expert Opinion on Drug Safety,volume 9,issue 2 , Vol. 9, Iss. 2, 2010-03 , pp.![](/images/ico/ico5.png)
By Sarafidis Pantelis A,Georgianos Panagiotis I,Lasaridis Anastasios N in (2010)
Expert Opinion on Drug Safety,volume 9,issue 2 , Vol. 9, Iss. 2, 2010-03 , pp.![](/images/ico/ico5.png)
By Sarafidis Pantelis A,Georgianos Panagiotis I,Lasaridis Anastasios N in (2010)
Expert Opinion on Drug Safety,volume 9,issue 2 , Vol. 9, Iss. 2, 2010-03 , pp.![](/images/ico/ico5.png)
Toxicity of sorafenib: clinical and molecular aspects
By Blanchet Benoit,Billemont Bertrand,Barete Stéphane,Garrigue Hélène,Cabanes Laure,Coriat Romain,Francès Camille,Knebelmann Bertrand,Goldwasser François in (2010)
Expert Opinion on Drug Safety,volume 9,issue 2 , Vol. 9, Iss. 2, 2010-03 , pp.![](/images/ico/ico5.png)
Benefit–risk assessment: the use of clinical utility index
Expert Opinion on Drug Safety,volume 9,issue 2 , Vol. 9, Iss. 2, 2010-03 , pp.![](/images/ico/ico5.png)
Safety profile of new anticancer drugs
By Mansi Laura,Thiery-Vuillemin Antoine,Nguyen Thierry,Bazan Fernando,Calcagno Fabien,Rocquain Julien,Demarchi Martin,Villanueva Cristian,Maurina Tristan,Pivot Xavier in (2010)
Expert Opinion on Drug Safety,volume 9,issue 2 , Vol. 9, Iss. 2, 2010-03 , pp.